Some of the most common pharmaceutical drugs for cardiovascular disease can have dangerous interactions with Pfizer’s new Wuhan coronavirus (Covid-19) drug Paxlovid. According to a new paper published in the Journal of the American College of Cardiology (JACC), Paxlovid’s combination of nirmatrelvir and ritonavir interacts negatively with the CYP450 pathway, which is involved in metabolizing a number of pharmaceutical medications. Ritonavir, … Continue reading Pfizer’s new Paxlovid antiviral drug is a dangerous ivermectin knockoff that causes “severe adverse effects”
Dr. Eddy Bettermann MD 